Pediatric melanoma: Analysis of an international registry

Cancer

Volumn 119, Issue 22, 2013, Pages 4012-4019

  Averbook, Bruce J ^a,b   Lee, Sandra J ^c   Delman, Keith A ^d   Gow, Kenneth W ^d,q   Zager, Jonathan S ^e,f   Sondak, Vernon K ^e,f   Messina, Jane L ^e,f   Sabel, Michael S ^g   Pittelkow, Mark R ^h   Ecker, Phillip M ^h,r   Markovic, Svetomir N ⁱ   Swetter, Susan M ^j   Leachman, Sancy A ^h,k   Testori, Alessandro ^l   Curiel Lewandrowski, Clara ^m   Go, Ronald S ^n,s   Jukic, Drazen M ^o,s   Kirkwood, John M ^p  

^a METROHEALTH MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^h MAYO CLINIC   (United States)

ⁱ STANFORD CANCER INSTITUTE   (United States)

^j UNIVERSITY OF UTAH   (United States)

^k EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^l UNIVERSITY OF ARIZONA   (United States)

^m GUNDERSEN HEALTH SYSTEM   (United States)

ⁿ UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^o UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^p UNIVERSITY OF WASHINGTON   (United States)

^q Minnesota Dermatology   (United States)

^r OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^s UNIVERSITY OF SOUTH FLORIDA   (United States)

more..

Author keywords

melanoma; mitotic rate; pediatric; sentinel lymph node biopsy; survival

Indexed keywords

ADOLESCENT; ADULT; CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; CARCINOMA IN SITU; CHILD; CONFERENCE PAPER; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TUMOR THICKNESS; ULCER;

MELANOMA; MITOTIC RATE; PEDIATRIC; SENTINEL LYMPH NODE BIOPSY; SURVIVAL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTERNATIONALITY; MALE; MELANOMA; PROGNOSIS; REGISTRIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 84887099210     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28289     Document Type: Conference Paper

References (29)

1. Strouse JJ, Fears T, Tucker MA, Wayne AS,. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end Results database. J Clin Oncol. 2005; 23: 4735-4741.
2. Jukic DM, Rao UN, Kelly L, et al. MicroRNA profiling analysis of differences between the melanoma of young adults and older adults. J Transl Med. 2010; 8: 27.
3. Bleyer A, O'Leary M, Barr R, Ries LAG, eds. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. NIH Pub. No. 06-5767. Bethesda, MD: National Cancer Institute; 2006.
4. Mones JM, Ackerman AB,. Melanomas in prepubescent children: review comprehensively, critique historically, criteria diagnostically, and course biologically. Am J Dermatopathol. 2003; 25: 223-238.
5. Pappo AS,. Melanoma in children and adolescents. Eur J Cancer. 2003; 39: 2651-2661.
6. Silverberg NB,. Update on malignant melanoma in children. Cutis. 2001; 67: 393-396.
7. Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics. 2005; 115: 649-654.
8. Lange JR, Palis BE, Chang DC, Soong SJ, Balch CM,. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base. J Clin Oncol. 2007; 25: 1363-1368.
9. Paradela S, Fonseca E, Pita-Fernandez S, et al. Prognostic factors in melanoma in children and adolescents: a clinicopathologic, single-centre study of 137 patients. Cancer. 2010; 15: 4334-4344.
10. Saenz NC, Saenz-Badillos J, Busam K, LaQuaglia MP, Corbally M, Brady MS,. Childhood melanoma survival. Cancer. 1999; 85: 750-754.
11. Conti EM, Cercato MC, Gatta G, Ramazzotti V, Roscioni S,; EUROCARE Working Group. Childhood melanoma in Europe since 1978: a population-based survival study. Eur J Cancer. 2001; 37: 780-784.
12. Melnik MK, Urdaneta LF, Al-Jurf AS, Foucar E, Jochimsen PR, Soper RT,. Malignant melanoma in childhood and adolescence. Am Surg. 1986; 52: 142-147.
13. Temple WJ, Mulloy RH, Alexander F, Marx LH, Jenkins M, Jerry LM,. Childhood melanoma. J Pediatr Surg. 1991; 26: 135-137.
14. Berg P, Wennberg AM, Tuominen R, et al. Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma. Melanoma Res. 2004; 14: 251-255.
15. Greene MH,. The genetics of hereditary melanoma and nevi: 1998 update. Cancer. 1999; 86 (suppl 11): 2464-2477.
16. Sander B, Karlsson P, Rosdahl I, Westermark P, Boeryd B,. Cutaneous malignant melanoma in Swedish children and teenagers 1973-1992: a clinicopathological study of 130 cases. Int J Cancer. 1999; 80: 646-651.
17. Berg P, Lindelof B,. Differences in malignant melanoma between children and adolescents. A 35-year epidemiological study. Arch Dermatol. 1997; 133: 295-297.
18. Lewis KG,. Trends in pediatric melanoma mortality in the United States, 1968 through 2004. Dermatol Surg. 2008; 34: 152-159.
19. Lange JR, Dunkel IF, Shaw HM, Sober AJ,. Melanoma in children and teenagers. In:, Balch CM, Houghton AN, Sober AJ, et al, eds. Cutaneous Melanoma. 5th ed. St. Louis, MO: Quality Medical Publishing, Inc; 2009: 351-361.
20. Gibbs P, Moore A, Robinson W, Walsh P, Golitz L, Gonzalez R,. Pediatric melanoma: are recent advances in the management of adult melanoma relevant to the pediatric population. J Pediatr Hematol Oncol. 2000; 22: 428-432.
21. Aldrink JH, Selim MA, Diesen DL, et al. Pediatric melanoma: a single-institution experience of 150 patients. J Pediatr Surg. 2009; 44: 1514-1521.
22. Livestro DP, Kaine EM, Michaelson JS, et al. Melanoma in the young: differences and similarities with adult melanoma-a case-matched controlled analysis. Cancer. 2007; 110: 614-624.
23. Moore-Olufemi S, Herzog C, Warneke C, et al. Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patients. Ann Surg. 2011; 253: 1211-1215.
24. Mu E, Lange JR, Strouse JJ,. Comparison of the use and Results of sentinel lymph node biopsy in children and young adults with melanoma. Cancer. 2012; 118: 2700-2707.
25. Thompson JA,. The revised American Joint Committee on Cancer staging system for melanoma. Semin Oncol. 2002; 29: 361-369.
26. Levell NJ, Beattie CC, Shuster S, Greenberg DC,. Melanoma epidemic: a midsummer night's dream? Br J Dermatol. 2009; 161: 630-634.
27. Daniotti M, Ferrari A, Frigerio S, et al. Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT. J Invest Dermatol. 2009; 129: 1759-1768.
28. Joosse A, de Vries E, Eckel R, et al; Munich Melanoma Group. Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol. 2011; 131: 719-726.
29. Joosse A, Collette S, Suciu S, et al. Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials. J Clin Oncol. 2012; 30: 2240-2247.